Adoptive therapy with CAR redirected T cells for hematological malignancies.

about

Genetically enhanced T lymphocytes and the intensive care unit.

P2860

Q55380614-5BF0D617-D6B1-42EE-891D-500F549BE4E3

P2860

Adoptive therapy with CAR redirected T cells for hematological malignancies.

Item

http://www.wikidata.org/entity/Q38786628

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Adoptive therapy with CAR redirected T cells for hematological malignancies.

@en

type

Item

label

Adoptive therapy with CAR redirected T cells for hematological malignancies.

@en

prefLabel

Adoptive therapy with CAR redirected T cells for hematological malignancies.

@en

P1476

Adoptive therapy with CAR redirected T cells for hematological malignancies.

@en

P2093

Cheng Qian

http://www.w3.org/2001/XMLSchema#string

Juanjuan Shan

http://www.w3.org/2001/XMLSchema#string

Junjie Shen

http://www.w3.org/2001/XMLSchema#string

Shiqi Li

http://www.w3.org/2001/XMLSchema#string

Zhi Yang

http://www.w3.org/2001/XMLSchema#string

P2860

Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia

T cells with chimeric antigen receptors have potent antitumor effects and can establish memory in patients with advanced leukemia

Chimeric antigen receptor T cells for sustained remissions in leukemia

Efficacy and toxicity management of 19-28z CAR T cell therapy in B cell acute lymphoblastic leukemia

Chimeric antigen receptor-modified T cells for acute lymphoid leukemia

CD19-targeted T cells rapidly induce molecular remissions in adults with chemotherapy-refractory acute lymphoblastic leukemia

Case report of a serious adverse event following the administration of T cells transduced with a chimeric antigen receptor recognizing ERBB2

B-cell depletion and remissions of malignancy along with cytokine-associated toxicity in a clinical trial of anti-CD19 chimeric-antigen-receptor-transduced T cells

Safety and persistence of adoptively transferred autologous CD19-targeted T cells in patients with relapsed or chemotherapy refractory B-cell leukemias

Current concepts in the diagnosis and management of cytokine release syndrome.

P2888

s11427-016-5036-3

P304

370-378

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11427-016-5036-3

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-03-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1022671856

http://www.w3.org/2001/XMLSchema#string

P698

27009302

http://www.w3.org/2001/XMLSchema#string

Adoptive therapy with CAR redirected T cells for hematological malignancies.

about

P2860

P2860

Adoptive therapy with CAR redirected T cells for hematological malignancies.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698